top of page

Professional

UPN Journal Ad.jpg
UPNEEQ Launch Campaign and Tactics

UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is indicated for the treatment of acquired blepharoptosis in adults.

UPN Web.png

Journal Ad

Patient Website

Program FC.png

Program Flashcard and Email

flshcrd_C.png
flshcrd_A.png
flshcrd_B.png

Promo Flashcards

HCP JA.png

Journal Ad

Lucemyra Campaign and Tactics

LUCEMYRA® is the only FDA-approved, non-opioid, non-addictive treatment for relief of multiple symptoms of opioid withdrawal that may happen when you stop taking an opioid suddenly

HCP PrintAd2-1.png

Addictionolgist Visual Aid

Journal Ad

HCP_web.png

HCP Website (evolved campaign)

HCP Banner Ad

Core CVA (evolved campaign)

OUD Brochure (evolved campaign)

In-Office Patient Poster (unbranded)

CVA cover.png
SEVENFACT Launch Campaign and Tactics

SEVENFACT [coagulation factor VIIa (recombinant)-jncw] is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors.

spread ad.png

Launch Visual Aid

Launch Journal Ad

SF web.png

Patient Website

banner ad.png

Banner Ad

email.png

CRM Email

unbranded ad.png

Disease Awareness / Corporate Campaign

booth.png

ASH Convention Booth

Concepts
EXO-1.png
EXO-4.png

ExosomeDx – ExoDx Prostate Test Concepts

EXO-5.png
UP_1.png
UP_6.png

Eyejuvid (now UPNEEQ) – Ptosis Concepts

UP_3.png
ATryn rethink-1.png
ATryn rethink-2.png

rEVO – ATryn Recombinant Antithrombin Concepts

​

ATryn Ad_1.png
ATryn Ad_3.png

rEVO – ATryn Recombinant Antithrombin Journal Ad Concepts

​

bottom of page